TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Response for Non-menstrual Pelvic Pain at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: SARS-COV-2 seroprevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: duration of analgesic free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average sleep latency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Occurrence of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: composite score of gastrointestinal tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants With Esophageal Thermal Injury
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Esophageal Injury Based on Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Major Molecular Response (MMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of excess limb volume (ELV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Achieve Hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vegetable Flavor Acceptance (Infants' Rate of Feeding)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Absolute Mean Change in Percent Predicted FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum Concentration (C max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Concentration (T max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deviation from the 0° axis in the coronar plain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deviation from the 0° axis in the sagittal plain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appealing proportion of nose width to eye-corner distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Rating Scale (6 Items)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to recurrent procedure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for tracheostomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PQRS recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve from dosing time to infinity (AUC(0-∞))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve from dosing time to last measurement (AUC(0-t))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants That Did NOT Experience Aneurysm-Related Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants With Successful Aneurysm Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart-Rate-Corrected Augmentation Index (AIx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Central Systolic Blood Pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Central Diastolic Blood Pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peripheral Systolic Blood Pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall survival from transplant
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who Live Longer Than Predicted
Endpoint domain: Mortality/survival
Primary endpoint: Percent Change of Wound Size From Baseline to Last Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of Target Ulcer at V6/EOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change of Target Ulcer From Baseline to Last Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of Hispanic to non-Hispanic white LDKTs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gestational Diabetes Mellitus incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PTSD Symptoms From Baseline as Measured by the Clinician Administered PTSD Scale - 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory at 14 Weeks as Measured by the Hopkins Verbal Memory Test - Revised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention and Working Memory From Baseline as Measured by the Wechsler Adult Intelligence Scale-4th Edition, Digit Span Subtest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant adherence to the cycle training course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cycle Champion interviews: acceptability of cycle training course delivery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant questionnaire: Likert scale of training course acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic test characteristics for TAPSE and PAAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Psychological Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Combined endpoint of death, stroke, non-index treatment related MI and new revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Perceived Stress Scale score reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence / prevalence of CVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptoms of Attention Deficit Hyperactivity Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroprevalence of antibodies anti-COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average perceived pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of virological cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean Change in Maximum Pain Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of vasopressor treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to reach Cmax (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration time curve from time 0 to time of the last measurable drug concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of PAA and PAGN following described treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration time curve over time (AUC0-t) of PAA and PAGN following described treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life (t1/2) of PAA and PAGN following a single 5 g dose of OCR-002 oral solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peritoneal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of adverse events after infusion of MSC (hPPL)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of severe infections after MSC infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in magnetic resonance signal intensity of segmented nerves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time of Maximum Observed Plasma Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Testosterone Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement of skin barrier function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in family economic hardship
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Concentrations of lipoproteins and glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolite concentrations in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Concentration-time Curve of Plasma Amlodipine From 0 to 72 Hours (AUC72)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resected cone mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: neural indices of distress tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triggering of the defibrillator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of SAE
Endpoint domain: Adverse events/effects
Primary endpoint: World Health Organization Quality of Life - Old Module
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: American Spinal Injury Association Scale - ASIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Vividness of motor imagery questionnaire (VMIQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean Change in Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With Endometrial Hyperplasia at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Participants Discontinuing Study Therapy Due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With HIV Ribonucleic Acid (RNA) <50 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virological response at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clindamycin clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of contralateral breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Hospital Readmission for CHF
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in plasma gastrin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Closure of arterial duct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain after IUD/IUS insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Balance (Berg Balance Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in trunk control and sitting Balance (Trunk Impairment Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Disposal of Unused Opioid Medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retinal nerve fiber thickness (RNFL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Body weight at 36 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c at 36 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage Changes of Serum Anti-Mullerian Hormone (AMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rates of vaginal or anal sex without condoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: WBC Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in Coronary Flow Reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serious hypoglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of symptomatic VTE
Endpoint domain: Mortality/survival
Primary endpoint: Number of Seroconverted Subjects for Anti-HPV-16 and Anti-HPV-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Seropositive Subjects for Anti-HPV-16 and Anti-HPV-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in colchicine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate based on best response observed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Second Treatment
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of an impairment at work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in the amount of vitamin E in buccal cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With an ACR20 Response at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Low Disease Activity Based on DAS28(CRP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Exacerbations Requiring Systemic Corticosteroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cmax Following Single Dose of Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC Following Single Dose of Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax Following Single Dose of Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination between malignant and nonmalignant breast lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in 24-hour ambulatory diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in the SF-36 Physical Component Summary (PCS) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time (Days) to Radiographic Healing of Tibial Fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Intelligence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance on Measures of Social Cognition
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Developmental abnormalities in pediatric patients with cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FLACC Pain Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to traverse the colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage prevalence of rotavirus positive cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Average Laser Setting for Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of high-grade adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Wear time of the Twin Block appliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLEDAI-2000 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in BDNF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thyrotoxic symptoms and signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of subsequent atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking Cessation Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalized Respiratory Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical Response at Test of Cure (TOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of stroke volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With Proven or Probable IFIs
Endpoint domain: Adverse events/effects
Primary endpoint: Posterior capsular opacification (PCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Preference on physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ACA flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pure tone audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tinnitus handicap inventory scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent change in LDL-C and HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Early wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Average postoperative shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival and disease-dependent survival over a period of at least 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Cure rates in terms of local, regional or distant recurrence events
Endpoint domain: Mortality/survival
Primary endpoint: Recovery time after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Successful Completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Japanese Orthopedic Association Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion rate of CRC screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hydration of facial skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death of patient
Endpoint domain: Mortality/survival
Primary endpoint: Prophylactic outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to taper to ≤7.5mg/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with viral load < 80 at the end of tuberculosis therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: proportion of adverse events in each group
Endpoint domain: Adverse events/effects
Primary endpoint: BMD measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complications related to non-invasive blood pressure cuff
Endpoint domain: Adverse events/effects
Primary endpoint: Signal noise ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality all causes at day 30
Endpoint domain: Mortality/survival
Primary endpoint: Vaccine immunogenicity (T cell responses)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Emergence delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Intervention for Any Mood Episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of dementia conversion or disease severity worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inhalants craving - PACS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhalants craving - VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Marriage
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Any Major Morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Mu-opioid Binding Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in BOLD Response During Reward fMRI Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Leukemic Stem Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Count of Patients With Recurrent Preterm Labor
Endpoint domain: Mortality/survival